Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.38

€1.38

-2.290%
-0.032
-2.290%
€3.50

€3.50

 
21.01.22 / Tradegate WKN: A0B65S / Name: Paion / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€2.00
27.12.21
11.87%
buy
€5.00
07.03.21
-38.30%
buy
Your prediction

Paion AG Stock

A loss of -2.290% shows a downward development for Paion AG.
The community is currently still undecided about Paion AG with 2 Buy predictions and 0 Sell predictions.
With a target price of €3.00 there is potential for a 118.023% increase which would mean more than doubling the current price of €1.38 for Paion AG.
Our community identified positive and negative aspects for Paion AG stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Paion AG stock. On the other hand our users think that "General Risks" could be a problem in the future.

Pros and Cons of Paion AG in the next few years

Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Paion AG vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Paion AG -2.290% -7.651% 12.602% -44.291% 13.907% -38.571% -49.449%
B.R.A.I.N. Biotechnology Research and Information Network AG -4.150% -3.673% 4.194% 6.306% 3.965% -25.079% -54.615%
MagForce AG -4.680% -4.240% 1.119% -43.542% -0.368% -52.951% -37.586%
Formycon AG -5.490% 0.209% -15.459% -23.317% -17.925% 68.486% 78.020%

Comments

Sell Paion AG
Show more

Prediction Buy
Perf. (%) -0.49%
Target price
Change
Ends at 02.01.20

Buy beendet
Show more

Buy Paion AG
Show more

Other discussions about Paion AG Stock

Trading Paion AG

Trading Paion AG

New thread Forum

News

DGAP-Adhoc: ​​​​​​​PAION ASSIGNS CHINESE REMIMAZOLAM PATENTS AND SELLS RELATED FUTURE ROYALTIES FOR EUR 20.5 MILLION TO HUMANWELL HEALTHCARE GROUP: https://upload.wikimedia.org/wikipedia/de/thumb/4/45/Paion-logo.svg/640px-Paion-logo.svg.png
DGAP-Adhoc: ​​​​​​​PAION ASSIGNS CHINESE REMIMAZOLAM PATENTS AND SELLS RELATED FUTURE ROYALTIES FOR EUR 20.5 MILLION TO HUMANWELL HEALTHCARE GROUP
DGAP-Adhoc: ​​​​​​​PAION ASSIGNS CHINESE REMIMAZOLAM PATENTS AND SELLS RELATED FUTURE ROYALTIES FOR EUR 20.5 MILLION TO HUMANWELL HEALTHCARE GROUP
DGAP-News: PAION SUBMITS EXTENSION APPLICATION OF MARKETING AUTHORIZATION FOR REMIMAZOLAM IN THE INDICATION GENERAL ANESTHESIA TO THE EUROPEAN MEDICINES AGENCY: https://upload.wikimedia.org/wikipedia/de/thumb/4/45/Paion-logo.svg/640px-Paion-logo.svg.png
DGAP-News: PAION SUBMITS EXTENSION APPLICATION OF MARKETING AUTHORIZATION FOR REMIMAZOLAM IN THE INDICATION GENERAL ANESTHESIA TO THE EUROPEAN MEDICINES AGENCY
DGAP-News: PAION SUBMITS EXTENSION APPLICATION OF MARKETING AUTHORIZATION FOR REMIMAZOLAM IN THE INDICATION GENERAL ANESTHESIA TO THE EUROPEAN MEDICINES AGENCY